| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/09/2008 | US7423067 Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists |
| 09/09/2008 | US7423057 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid |
| 09/09/2008 | US7423055 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
| 09/09/2008 | US7423049 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 09/09/2008 | US7423047 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 09/09/2008 | US7423042 Compounds |
| 09/09/2008 | US7423020 Therapy for behavior disorders; quantitative analysis; measuring binding |
| 09/09/2008 | US7423007 Cxcr4 antagonist and use thereof |
| 09/09/2008 | US7422906 Apoptosis-inducing gene and utilization of the same |
| 09/09/2008 | US7422890 Polynucleotide that encodes a polypeptide having activity as a phospholipase A2 inhibitor; especially obtained from the liver of a species of Python |
| 09/09/2008 | US7422846 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 09/09/2008 | US7422756 Mixture of fatty acid and cholesterol |
| 09/09/2008 | US7422733 Antiinflammatory agents; anticancer agents; antidiabetic agents |
| 09/09/2008 | CA2366205C Biphenyl derivatives |
| 09/09/2008 | CA2346868C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 09/09/2008 | CA2332389C Liposomal preparations for the application of antiseptic agents to the interior of the body |
| 09/09/2008 | CA2323086C Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/09/2008 | CA2181689C Guanylhydrazones for treating inflammatory conditions |
| 09/04/2008 | WO2008106373A1 Product containing inactivated probiotic for children or infants |
| 09/04/2008 | WO2008106372A1 Method for treating or preventing systemic inflammation |
| 09/04/2008 | WO2008105540A1 Pharmaceutical agent and food effective on allergic disease and autoimmune disease |
| 09/04/2008 | WO2008105526A1 Macrocyclic compound |
| 09/04/2008 | WO2008105498A1 Pharmaceutical composition for ameliorating inflammation induced by il-17 |
| 09/04/2008 | WO2008105442A1 Sulfonamide derivative |
| 09/04/2008 | WO2008105436A1 TUMOR NECROSIS FACTOR-α INHIBITOR AND PROSTAGLANDIN SYNTHASE-2 INHIBITOR |
| 09/04/2008 | WO2008105386A1 Rexinoid compound having alkoxy group |
| 09/04/2008 | WO2008105384A1 Citrulline-containing tablet |
| 09/04/2008 | WO2008105383A1 Pyrazole derivative and use thereof for medical purposes |
| 09/04/2008 | WO2008104175A2 Novel phosphodiesterase inhibitors |
| 09/04/2008 | WO2008047229A3 Biaryl ether urea compounds |
| 09/04/2008 | WO2007121924A3 Bisadenosine compounds as adenosine a2a receptor agonists |
| 09/04/2008 | US20080214785 Heterodimeric receptor complex which antagonizes IL-10-related T cell-derived inducible factor for use in diagnosis, treatment and prevention of spleen associated cell proliferative disorders |
| 09/04/2008 | US20080214781 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 09/04/2008 | US20080214664 Anesthetic spray composition |
| 09/04/2008 | US20080214661 Process To Obtain Dibenzylbutyrolactonic, Tetrahydrofuranic Lignans And Their Synthetic And Semi-Synthetic Derivatives, Their Analgesic And Anti-Inflammatory Activities, Topical And/Or Systemic Formulations Containing Said Lignans And Their Respective Therapeutic Method |
| 09/04/2008 | US20080214660 Compounds and Methods for the Inhibition of the Expression of VCAM-1 |
| 09/04/2008 | US20080214646 Novel Nsaids Possessing a Nitric Oxide Donor Diazen-1-Ium-1,2-Diolate Moiety |
| 09/04/2008 | US20080214641 Chemical compounds 572 |
| 09/04/2008 | US20080214638 To treat diseases of lipid metabolism, cardiovascular disease, inflammatory diseases; selective agonists of the nicotinic acid receptor; 2-{[(4-Biphenylyloxy)acetyl]amino}-4-(methyloxy)benzoic acid |
| 09/04/2008 | US20080214623 N-(2,2-Dimethylpropyl)-6-{3-fluoro-5-[(3-isoxazolylamino)carbonyl]-2-methylphenyl}-3-pyridinecarboxamide; inhibitors of p38 kinase |
| 09/04/2008 | US20080214602 N-Biarylamides |
| 09/04/2008 | US20080214601 2-alkylbenzoxazole carboxamides as 5ht3 modulators |
| 09/04/2008 | US20080214597 Tricyclic Lactam Derivatives as 11-Beta Hydroxysteroid Dehydrogenase Inhibitors |
| 09/04/2008 | US20080214591 N-Aryl Diazaspirocyclic Compounds and Methods of Preparation and Use Thereof |
| 09/04/2008 | US20080214586 2-Amino-4-Phenylquinazoline Derivatives and the Use Thereof as Hsp90 Modulators |
| 09/04/2008 | US20080214583 2-amino-4,5-dimethyl-1-(3-chlorophenyl)-1H-pyrrolo-3-carbonitrile; asthma, eczema or psoriasis |
| 09/04/2008 | US20080214581 anti-inflammatory; (2R,3S,4R,5R)-2-(2-ethyl-2H-tetrazol-5-yl)-5-[2-{[2-(1H-imidazol-4-yl)ethyl]amino}-6-({trans-4-[(2-{[2-(1H-imidazol-4-yl)ethyl]amino}-1H-purin-6-yl)amino]cyclohexyl}amino)-9H-purin-9-yl]tetrahydro-3,4-furandiol; immunosuppressive agents use in treatment of auto-immune diseases |
| 09/04/2008 | US20080214575 Piperidine derivatives useful as ccr5 antagonists |
| 09/04/2008 | US20080214544 N-(4-(6-(1-methyl-6-oxo-2-(phenylamino)-1,6-dihydropyrimidin-5-yl)pyridin-3-yloxy)pyridin-2-yl)pyrrolidine-1-carboxamide; anticarcinogenics, antiproliferatives, angiogenesis inhibitors; hepatocyte growth factor mediated diseases |
| 09/04/2008 | US20080214478 Small Peptides And Methods For Inhibiting The Infiltration Of Eosinophils Into Airways |
| 09/04/2008 | US20080214477 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting t-cell migration; immunotherapy |
| 09/04/2008 | US20080214476 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting mucous release into airways of patients; immunotherapy |
| 09/04/2008 | US20080214475 Small Peptides And Methods For Inhibiting The Mucous Release Into Airways |
| 09/04/2008 | US20080214474 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease |
| 09/04/2008 | US20080214473 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; treatment and prevention of respiratory system disorders; antiinflammatory agents; immunotherapy |
| 09/04/2008 | US20080214472 Small Peptides And Methods For Treatment Of Arthritis |
| 09/04/2008 | US20080214454 Use of HMGB fragments as anti-inflammatory agents |
| 09/04/2008 | US20080214453 Administering soluble receptor for advanced glycation endproduct (sRAGE) |
| 09/04/2008 | US20080214440 Pituitary adenylate cyclase activating peptide; solid phase synthesis; diabetes, insulin resistance, metabolic acidosis and obesity |
| 09/04/2008 | US20080214437 RNA interference; gene therapy; inhalers |
| 09/04/2008 | US20080213793 Antibodies that bind receptor protein designated 2f1 |
| 09/04/2008 | US20080213776 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same |
| 09/04/2008 | US20080213382 Thermotherapy susceptors and methods of using same |
| 09/04/2008 | US20080213361 Coat sodium ibuprofenate crystals with finely divided silica excipient; microcrystalline cellulose; crosslinked polyvinylpyrrolidone binder; mannitol filler; stearic acid disintegrant; poloxamer lubricant; simpler, more cost-efficient; roll compaction, agglomerate, granulate; conventional compression |
| 09/04/2008 | US20080213351 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 09/04/2008 | US20080213339 Pharmaceutical Composition Containing Indometacin and/or Acemetacin |
| 09/04/2008 | US20080213313 Botulinum toxin treatments |
| 09/04/2008 | US20080213259 Methods for Treating Autoimmune and Chronic Inflammatory Conditions Using Antagonists of CD30 or CD30L |
| 09/04/2008 | US20080213246 Supplements For Pain Management |
| 09/04/2008 | US20080213236 Natural Remedy-Dietary Supplement Combination Product |
| 09/04/2008 | US20080213227 Using animal progenitor cell culture to propagate organ tissues; tissue engineering; tissue repair; regenerative medicine; treating cell proliferative, arthritic, autoimmune, skin and inflammatory disorders |
| 09/04/2008 | US20080213216 Transgenic lymphocytes comprising expression vector coding Fc receptor for use in identifying modulators for prevention and treatment of ifection and immune system disorders |
| 09/04/2008 | DE202008006708U1 Kombination von Tocotrienolen mit langkettigen Fettsäuren für Gesunderhaltung, Schmerzlinderung und Entzündungshemmung Combination of tocotrienols with long-chain fatty acids for healthy, relieve pain and inflammation |
| 09/04/2008 | CA2679374A1 Method for treating or preventing systemic inflammation |
| 09/04/2008 | CA2679263A1 Sulfonamide compound |
| 09/04/2008 | CA2679126A1 Macrocyclic compound |
| 09/04/2008 | CA2676956A1 Product containing inactivated probiotic for children or infants |
| 09/04/2008 | CA2676933A1 Novel phosphodiesterase inhibitors |
| 09/03/2008 | EP1964845A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1964844A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1964574A1 Method for treatment or prevention of disease associated with functional disorder of regulatory t cell |
| 09/03/2008 | EP1964570A1 Pharmaceutical compound to protect against allergies and inflammatory illnesses |
| 09/03/2008 | EP1964565A1 3,11b-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation |
| 09/03/2008 | EP1964561A1 Inhibitors of IMPDH enzyme |
| 09/03/2008 | EP1964552A1 Analgesic composition of topically applied nonsteoridal antiinflammatory drugs and opioids |
| 09/03/2008 | EP1963350A1 Biologically active compounds |
| 09/03/2008 | EP1963334A1 Chromone derivatives useful as antagonists of vr1 receptors |
| 09/03/2008 | EP1963322A1 Bicyclic heteroyclic compounds as antiinflammatory agents |
| 09/03/2008 | EP1963288A1 Substituted oxazole derivatives with an analgesic action |
| 09/03/2008 | EP1963287A1 Glucocorticoid receptor modulators as antiinflammatory agents |
| 09/03/2008 | EP1963285A1 Bradykinin 1 receptor antagonists |
| 09/03/2008 | EP1963283A2 Trisubstituted quinazolinone derivatives as vanilloid antagonists |
| 09/03/2008 | EP1963282A1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs |
| 09/03/2008 | EP1963276A1 N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation |
| 09/03/2008 | EP1963275A2 P2x7 receptor antagonists and uses thereof |
| 09/03/2008 | EP1963270A1 Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents |
| 09/03/2008 | EP1963261A1 Biaryl substituted nitrogen containing heterocycle inhibitors of lta4h for treating inflammation |
| 09/03/2008 | EP1963255A1 Synephrine derivatives useful as anti-inflammatory agents |
| 09/03/2008 | EP1962855A2 Trpa1 inhibitors for treating pain |
| 09/03/2008 | EP1962842A1 Diaryl ureas for treating inflammatory skin, eye and/or ear diseases |